The current fragmentation in all aspects of personalized
medicine research leads to a waste of money, crippled data and
failure of biomarkers to enter the clinic, says pathologist Gerrit
Meijer. On Wednesday November 22nd he will give his inaugural
lecture as professor of oncologic pathology at Utrecht University.
Prior to the lecture a symposium about innovations in this field
will be held.
Unexpected finding solves 40-year old cytoskeleton mystery
Scientists have been searching for it for decades: the enzyme
that cuts the amino acid tyrosine off an important part of the
cell's skeleton. Researchers of the Netherlands Cancer Institute
have now identified this mystery player, which may be of vital
importance to the understanding of cell function and division, and
therefore the understanding of cancer. They publish their finding
in Science on November 16th.